Table: Mochida Pharm -Q1 group results

Mochida Pharmaceutical

03/08/2026 06:00

    Aug 3 (Reuters)- 
             Mochida Pharmaceutical Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended       Year to 
                Jun 30, 2026        Jun 30, 2025     Mar 31, 2027 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             31.72               26.63           126.00    
                 (+19.1 pct)         (+4.8 pct)       (+7.7 pct)  
  Operating          3.56                2.57            10.50    
                 (+38.5 pct)         (+17.5 pct)      (+3.5 pct)  
  Recurring          4.19                2.78            12.50    
                 (+50.5 pct)         (+17.6 pct)      (+11.6 pct) 
  Net                3.18                1.89            10.00    
                 (+67.8 pct)         (+21.8 pct)      (+26.5 pct) 
  EPS             89.77 yen           53.43 yen       282.86 yen  
  Ann Div                             80.00 yen        85.00 yen  
  -Q2 div                             40.00 yen        42.50 yen  
  -Q4 div                             40.00 yen        42.50 yen  
  
  NOTE - Mochida Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4534.T